Life Molecular Imaging
Business Services · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Tegeler St 6-7, Berlin, Berlin, 13353, G...Phone Number
+49 30461124603Website
www.life-mi.comRevenue
$64.1 MillionIndustry
About Life Molecular Imaging
Life Molecular Imaging specializes in developing innovative molecular imaging tracers for neuroimaging and cardiovascular imaging, aiming to improve the early detection and characterization of chronic and life-threatening diseases. Their lead product, Neuraceq, is used in PET imaging to evaluate beta amyloid neuritic plaque density in patients suspected of Alzheimer's disease. The company collaborates with pharmaceutical partners and is engaged in research and development to address clinical needs in neurology and cardiology. They focus on enhancing diagnostic capabilities and personalizing patient care to improve therapeutic outcomes.Explore more
Life Molecular Imaging Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Life Molecular Imaging
Compare insights from companies similar to Life Molecular Imaging, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Life Molecular Imaging
$64.1M
51-200
Private
<$5M
2012
MT
Matthew TrifiloVice President & Head of Medical Affairs
Life Molecular Imaging Tech Stack
A closer look at the technologies used by Life Molecular Imaging
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Life Molecular Imaging
Sign Up For FreeTo access detailed company insights
Life Molecular Imaging specializes in developing innovative molecular imaging tracers for neuroimaging and cardiovascular imaging, aiming to improve the early detection and characterization of chronic and life-threatening diseases. Their lead product, Neuraceq, is used in PET imaging to evaluate beta amyloid neuritic plaque density in patients susp... Read More
